We are excited to welcome Greg Erman to the RiverWalk Therapeutics, Inc. Board of Directors! Greg was an important part of our MassBio #MassBioDrive mentor team last year. We decided to strengthen and make that relationship permanent by inviting him to join our Board of Directors. Greg is a serial entrepreneur and mentor in the #lifescienceindustry. As the founder/CEO of 6 companies, Greg raised ~$100M in venture capital and successfully grew his businesses to ~$20M in annual revenue and 150 employees. Each of his 3 VC-backed startups exited to large public companies while generating returns of up to 12X investment. The businesses he built are diverse and cut across many industries in the fields of #biotech, medical devices, and digital health. Greg was the first Entrepreneur-in-Residence at Mass General Brigham where he collaborated on over 250 life science research projects and spun-out multiple startups within a 10-year period. He was most recently the President & CEO of EmpiraMed, Inc., a decentralized clinical trials company with a unique platform to generate real world evidence for late stage and commercial biopharmaceutical assets. He and his co-founders pioneered the field of virtual, site-less clinical trials. Greg holds BS in Electrical Engineering and an MBA in Marketing with high honors from Rutgers University, sits on several biotech corporate boards, is an #angelinvestor, and is a part-time paid #entrepreneurship lecturer at Harvard Medical School. Greg gives back to the community volunteering as a mentor for several large institutions, as well as serving on the boards of non-profit organizations. Greg is an avid coastal sailor, racer, jazz trumpeter, and tennis player.
Greg’s start-up, fund-raising, and managerial experience will be an invaluable asset to help RiverWalk successfully develop a first-in-class therapeutic for the treatment of metastatic triple negative breast cancer. Welcome Greg!
